Cell-based Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, Services), Application (Drug Discovery, Research), End User (CROs, Biopharma Companies, Research Institutes), Geography - Global Forecast to 2024

Table of Contents

1.... INTRODUCTION

1.1            OBJECTIVES OF THE STUDY
1.2            MARKET DEFINITION
1.2.1               MARKETS COVERED.. 16
1.2.2               YEARS CONSIDERED FOR THE STUDY
1.3            CURRENCY
1.4            LIMITATIONS
1.5            STAKEHOLDERS

2.... RESEARCH METHODOLOGY

2.1.1               SECONDARY DATA
2.1.1.1             KEY DATA FROM SECONDARY SOURCES
2.1.2               PRIMARY DATA
2.1.2.1             KEY DATA FROM PRIMARY SOURCES
2.2            MARKET SIZE ESTIMATION
2.2.1               BOTTOM-UP APPROACH
2.2.2               TOP-DOWN APPROACH.. 22
2.3            MARKET BREAKDOWN AND DATA TRIANGULATION
2.4            ASSUMPTIONS FOR THE STUDY

3.... EXECUTIVE SUMMARY

4.... PREMIUM INSIGHTS

4.1            CELL-BASED ASSAYS: MARKET OVERVIEW
4.2            CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE AND APPLICATION (2018)
4.3            GEOGRAPHICAL SNAPSHOT OF THE CELL-BASED ASSAYS MARKET

5.... MARKET OVERVIEW

5.1            INTRODUCTION
5.2            MARKET DYNAMICS
5.2.1               DRIVERS
5.2.1.1             GROWING PREFERENCE FOR CELL-BASED ASSAYS
5.2.1.2             GROWING RESEARCH FUNDING
5.2.1.3             GROWTH IN THE NUMBER OF DRUG DISCOVERY ACTIVITIES
5.2.2               RESTRAINT
5.2.2.1             HIGH COST OF INSTRUMENTS AND RESTRICTIONS ON REAGENT USE
5.2.3               OPPORTUNITIES
5.2.3.1             HIGH-GROWTH ASIAN COUNTRIES
5.2.3.2             APPLICATION OF NOVEL CELL-BASED ASSAYS IN CANCER RESEARCH

6.... CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE

6.1            INTRODUCTION
6.2            CONSUMABLES
6.2.1               REAGENTS
6.2.1.1             REAGENTS HAVE WIDESPREAD USAGE IN LIFE SCIENCES DUE TO THEIR APPLICATION IN IMMUNOLOGY RESEARCH, DISEASE RESEARCH, AND CANCER DIAGNOSTICS
6.2.2               ASSAY KITS
6.2.2.1             REPORTER GENE ASSAYS
6.2.2.1.1             REPORTER GENE ASSAYS CAN BE USED WITH LIMITED RESOURCES FOR THE ESTABLISHMENT OF HTS PLATFORMS, PRESENTING OPPORTUNITIES FOR SMALL LABORATORIES WITH LIMITED RESOURCES
6.2.2.2             SECOND MESSENGER ASSAYS
6.2.2.2.1             SECOND MESSENGER ASSAYS ALLOW THE DETECTION AND CHARACTERIZATION OF ALL COMPOUND CLASSES—A KEY DRIVER FOR MARKET GROWTH
6.2.2.3             CELL GROWTH ASSAYS
6.2.2.3.1             CELL VIABILITY AND CELL PROLIFERATION ASSAYS ARE THE TWO MOST IMPORTANT IN VITRO QUANTIFICATION TECHNIQUES FOR ASSESSING CELL GROWTH
6.2.2.4             CELL DEATH ASSAYS
6.2.2.4.1             CELL DEATH QUANTIFICATION IS ESSENTIAL IN DRUG DEVELOPMENT TO IDENTIFY THE MANNER IN WHICH POTENTIAL DRUGS COULD INHIBIT OR ENHANCE MOLECULAR TARGETS—A KEY FACTOR PROPELLING MARKET DEMAND
6.2.2.5             OTHER ASSAY KITS
6.2.3               PROBES & LABELS
6.2.3.1             EFFECTIVE LABELING OF CELLS HELPS IN STUDYING CELLULAR EVENTS IN A SPATIAL AND TEMPORAL CONTEXT—A KEY FACTOR DRIVING THE DEMAND FOR PROBES AND LABELS
6.2.4               MICROPLATES
6.2.4.1             INCREASING DEMAND FOR CELL-BASED ASSAYS IN DRUG DISCOVERY, BASIC RESEARCH, AND PRECLINICAL SAFETY STUDIES IS ENCOURAGING THE CONSUMPTION OF MICROPLATES
6.2.5               CELL LINES
6.2.5.1             IMMORTALIZED CELL LINES
6.2.5.1.1             ADVANTAGES OF IMMORTALIZED CELL LINES CREATING A DEMAND FOR THESE CELL LINES OVER PRIMARY AND STEM CELL LINES
6.2.5.2             PRIMARY CELL LINES
6.2.5.2.1             PRIMARY CELL LINES ARE MORE SENSITIVE AS COMPARED TO IMMORTALIZED CELL LINES—A KEY FACTOR LIMITING MARKET GROWTH
6.2.5.3             STEM CELL LINES
6.2.5.3.1             STEM CELL LINES ARE ALTERNATIVE METHODOLOGIES TO ADDRESS THE CELLULARITY ISSUES THAT INVOLVE THE DIRECTED DIFFERENTIATION OF EMBRYONIC STEM (ES) CELLS OR INDUCED PLURIPOTENT STEM CELLS (IPS)
6.2.6               OTHER CONSUMABLES. 50

6.3            INSTRUMENTS
6.3.1               BIOTECHNOLOGY COMPANIES AIM TO STREAMLINE THEIR WORKFLOWS TO IMPROVE PRODUCTIVITY AND REDUCE COSTS, WHICH WILL DRIVE THE GROWTH OF THE INSTRUMENTS MARKET
6.4            SERVICES

7.... CELL-BASED ASSAYS MARKET, BY APPLICATION

7.1            INTRODUCTION
7.2            DRUG DISCOVERY
7.2.1               TOXICITY STUDIES. 56
7.2.1.1             INCREASING ADOPTION OF HIGH-CONTENT SCREENING FOR EVALUATING CYTOTOXICITY IS A FACTOR STIMULATING THE USE OF CELL-BASED ASSAYS FOR TOXICITY STUDIES
7.2.2               PHARMACOKINETIC STUDIES
7.2.2.1             DEMAND FOR ADME STUDIES TO RISE DUE TO THE GROWING NEED FOR IMPROVED CLINICAL SUCCESS—A MAJOR FACTOR DRIVING GROWTH
7.2.3               PHARMACODYNAMIC STUDIES
7.2.3.1             INCREASING NUMBER OF PHARMACODYNAMICS STUDIES GLOBALLY TO DRIVE GROWTH IN THE CELL-BASED ASSAYS MARKET
7.3            BASIC RESEARCH
7.3.1               INCREASING FUNDING BY GOVERNMENT INSTITUTES FOR BASIC RESEARCH TO DRIVE THE DEMAND FOR CELL-BASED ASSAY PRODUCTS & SERVICES
7.4            OTHER APPLICATIONS

8.... CELL-BASED ASSAYS MARKET, BY END USER. 61

8.1            INTRODUCTION
8.2            PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1               THE DEMAND FOR CELL-BASED ASSAYS IN THIS END-USER SEGMENT IS PRIMARILY DRIVEN BY THE GROWTH IN THE NUMBER OF R&D ACTIVITIES
8.3            ACADEMIC & GOVERNMENT INSTITUTES. 64
8.3.1               INCREASING INTEREST OF ACADEMIC INSTITUTIONS TO DEVELOP ASSAYS FOR INNOVATIVE APPLICATIONS TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN THIS END-USER SEGMENT
8.4            CONTRACT RESEARCH ORGANIZATIONS
8.4.1               GROWTH IN OUTSOURCING TO DRIVE THE DEMAND FOR CELL-BASED ASSAYS IN CONTRACT RESEARCH ORGANIZATIONS

9.... CELL-BASED ASSAYS MARKET, BY REGION

9.1            INTRODUCTION
9.2            NORTH AMERICA
9.2.1               US
9.2.2               CANADA

9.3            EUROPE
9.3.1               UK
9.3.2               GERMANY
9.3.3               FRANCE
9.3.4               REST OF EUROPE
9.4            ASIA PACIFIC
9.4.1               CHINA
9.4.2               JAPAN
9.4.3               INDIA
9.4.4               REST OF ASIA PACIFIC
9.5            REST OF THE WORLD

10.. COMPETITIVE LANDSCAPE

10.1          OVERVIEW
10.2          MARKET RANKING ANALYSIS, 2017
10.2.1             CELL-BASED ASSAYS MARKET RANKING, BY KEY PLAYER, 2017
10.3          KEY STRATEGIES
10.3.1             PRODUCT LAUNCHES, 2015–2018
10.3.2             EXPANSIONS, 2015–2018
10.3.3             COLLABORATIONS, 2015–2018:
10.3.4             ACQUISITIONS, 2015–2018
10.4          COMPETITIVE LEADERSHIP MAPPING (2017) 97
10.5          VISIONARY LEADERS
10.6          INNOVATORS
10.6.1             DYNAMIC DIFFERENTIATORS
10.6.2             EMERGING COMPANIES
10.7          COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2017)
10.7.1             PROGRESSIVE COMPANIES
10.7.2             STARTING BLOCKS. 99
10.7.3             RESPONSIVE COMPANIES
10.7.4             DYNAMIC COMPANIES. 99

11.. COMPANY PROFILES

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, SWOT ANALYSIS, MNM VIEW)*
11.1          THERMO FISHER SCIENTIFIC INC.
11.2          DANAHER CORPORATION
11.3          BECTON, DICKINSON AND COMPANY
11.4          GE HEALTHCARE
11.5          MERCK KGAA
11.6          LONZA GROUP LTD.
11.7          PERKINELMER, INC.
11.8          CHARLES RIVER LABORATORIES, INC.
11.9          CELL SIGNALING TECHNOLOGY, INC.
11.10       PROMEGA CORPORATION
11.11       CISBIO
11.12       CELL BIOLABS, INC.
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, SWOT ANALYSIS, MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
12.. APPENDIX
12.1          INSIGHTS OF INDUSTRY EXPERTS
12.2          DISCUSSION GUIDE
12.3          KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4          AVAILABLE CUSTOMIZATIONS
12.5          RELATED REPORTS
12.6          AUTHOR DETAILS

LIST OF TABLES

TABLE 1               CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 2               CELL-BASED CONSUMABLES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 3               CELL-BASED CONSUMABLES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 4               CELL-BASED REAGENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 5               CELL-BASED ASSAY KITS MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 6               CELL-BASED ASSAY KITS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 7               REPORTER GENE ASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 8               SECOND MESSENGER ASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 9               CELL GROWTH ASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 10             CELL DEATH ASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 11             OTHER ASSAY KITS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 12             CELL-BASED PROBES & LABELS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 13             CELL-BASED MICROPLATES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 14             CELL LINES MARKET, BY TYPE, 2017–2024 (USD MILLION)
TABLE 15             CELL LINES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 16             IMMORTALIZED CELL LINES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 17             PRIMARY CELL LINES MARKET FOR, BY REGION, 2017–2024 (USD MILLION)
TABLE 18             STEM CELL LINES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 19             OTHER CONSUMABLES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 20             CELL-BASED INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 21             CELL-BASED ASSAY SERVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 22             CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 23             CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY, BY REGION,
2017–2024 (USD MILLION)
TABLE 24             CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY, BY TYPE,
2017–2024 (USD MILLION)
TABLE 25             CELL-BASED ASSAYS MARKET FOR TOXICITY STUDIES, BY REGION,
2017–2024 (USD MILLION)
TABLE 26             CELL-BASED ASSAYS MARKET FOR PHARMACOKINETIC STUDIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 27             CELL-BASED ASSAYS MARKET FOR PHARMACODYNAMIC STUDIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 28             CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY REGION,
2017–2024 (USD MILLION)
TABLE 29             CELL-BASED ASSAYS MARKET FOR OTHER APPLICATIONS, BY REGION,
2017–2024 (USD MILLION)
TABLE 30             CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 31             CELL-BASED ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017–2024 (USD MILLION)
TABLE 32             CELL-BASED ASSAYS MARKET FOR ACADEMIC & GOVERNMENT INSTITUTES,
BY REGION, 2017–2024 (USD MILLION)
TABLE 33             CELL-BASED ASSAYS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS,
BY REGION, 2017–2024 (USD MILLION)
TABLE 34             CELL-BASED ASSAYS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 35             NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY,
2017–2024 (USD MILLION)
TABLE 36             NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES, 2017–2024 (USD MILLION)
TABLE 37             NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 38             NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION)
TABLE 39             US: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES,
2017–2024 (USD MILLION)
TABLE 40             US: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 41             US: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 42             CANADA: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES,
2017–2024 (USD MILLION)
TABLE 43             CANADA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 44             CANADA: CELL-BASED ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION)
TABLE 45             EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 46             EUROPE: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERIVECS,
2017–2024 (USD MILLION)
TABLE 47             EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 48             EUROPE: CELL-BASED ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION)
TABLE 49             UK: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES,
2017–2024 (USD MILLION)
TABLE 50             UK: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 51             UK: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 52             GERMANY: CELL-BASED ASSAYS MARKET, BY PRODUCTS & SERVICES,
2017–2024 (USD MILLION)
TABLE 53             GERMANY: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 54             GERMANY: CELL-BASED ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION)
TABLE 55             FRANCE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 56             FRANCE: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 57             FRANCE: CELL-BASED ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION)
TABLE 58             ROE: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 59             ROE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 60             ROE: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 61             APAC: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 62             APAC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 63             APAC: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 64             APAC: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 65             CHINA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 66             CHINA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 67             CHINA: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 68             JAPAN: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 69             JAPAN: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 70             JAPAN: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 71             INDIA: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 72             INDIA: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 73             INDIA: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 74             ROAPAC: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 75             ROAPAC: CELL-BASED ASSAYS MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 76             ROAPAC: CELL-BASED ASSAYS MARKET, BY END USER,
2017–2024 (USD MILLION)
TABLE 77             ROW: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 78             ROW: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 79             ROW: CELL-BASED ASSAYS MARKET, BY END USER, 2017–2024 (USD MILLION)

LIST OF FIGURES

FIGURE 1   RESEARCH DESIGN

FIGURE 2             BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION
FIGURE 3             CELL-BASED ASSAYS MARKET: BOTTOM-UP APPROACH
FIGURE 4             CELL-BASED ASSAYS MARKET: TOP-DOWN APPROACH
FIGURE 5             DATA TRIANGULATION METHODOLOGY
FIGURE 6             CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE,
2019 VS. 2024 (USD MILLION)
FIGURE 7             CELL-BASED ASSAYS MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
FIGURE 8             CELL-BASED ASSAYS MARKET, BY END USER, 2019 VS. 2024 (USD MILLION)
FIGURE 9             CELL-BASED ASSAYS MARKET, BY REGION, 2019 VS. 2024 (USD MILLION)
FIGURE 10          GROWTH IN THE NUMBER OF DRUG DISCOVERY ACTIVITIES IS DRIVING THE DEMAND FOR CELL-BASED ASSAYS
FIGURE 11          DRUG DISCOVERY APPLICATIONS ACCOUNTED FOR THE LARGEST SHARE OF
THE CELL-BASED ASSAYS MARKET IN 2018
FIGURE 12          COUNTRIES IN APAC TO REGISTER A HIGHER GROWTH RATE DURING
THE FORECAST PERIOD
FIGURE 13          CELL-BASED ASSAYS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 14          CONSUMABLES TO DOMINATE THE CELL-BASED ASSAYS MARKET DURING
THE FORECAST PERIOD
FIGURE 15          DRUG DISCOVERY APPLICATIONS TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 16          PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ESTIMATED TO BE THE LARGEST END USERS OF CELL-BASED ASSAYS DURING THE FORECAST PERIOD
FIGURE 17          NORTH AMERICA TO DOMINATE THE CELL-BASED ASSAYS MARKET
FIGURE 18          NORTH AMERICA: CELL-BASED ASSAY MARKET SNAPSHOT
FIGURE 19          APAC: CELL-BASED ASSAYS MARKET SNAPSHOT
FIGURE 20          KEY DEVELOPMENTS IN THE CELL-BASED ASSAYS MARKET FROM 2015 TO 2019
FIGURE 21          MNM DIVE-VENDOR COMPARISON MATRIX: CELL-BASED ASSAYS MARKET
FIGURE 22          MNM DIVE-VENDOR COMPARISON MATRIX FOR START-UPS: CELL-BASED
ASSAYS MARKET
FIGURE 23          THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2017)
FIGURE 24          DANAHER CORPORATION: COMPANY SNAPSHOT (2018)
FIGURE 25          BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018)
FIGURE 26          GE HEALTHCARE: COMPANY SNAPSHOT (2018)
FIGURE 27          MERCK KGAA: COMPANY SNAPSHOT (2017)
FIGURE 28          LONZA GROUP LTD.: COMPANY SNAPSHOT (2017)
FIGURE 29          PERKINELMER, INC.: COMPANY SNAPSHOT (2018)
FIGURE 30          CHARLES RIVER LABORATORIES, INC.: COMPANY SNAPSHOT (2017)

当レポートのプレスリリースは発行されておりません。